Description

Product Description

Degarelix Acetate is a decapeptide GnRH receptor antagonist synthesized to selectively inhibit GnRH receptor activation in laboratory research. By competitively binding to GnRH receptors in the pituitary gland, Degarelix prevents receptor-mediated signaling that normally stimulates luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release. This blockade allows researchers to study testosterone modulation, feedback mechanisms, and endocrine axis dynamics in preclinical and in vitro models.

From a molecular perspective, Degarelix Acetate interacts with the GnRH receptor through high-affinity peptide-receptor binding. Experimental data demonstrate that this interaction leads to rapid receptor antagonism without initial stimulation (“flare”), making it a useful tool for mechanistic studies in endocrine biology. Laboratory research often explores dose-response effects, receptor occupancy, pharmacokinetics, and peptide stability to optimize experimental protocols.

Key experimental applications of Degarelix Acetate include:

• Endocrine axis studies: Investigating hypothalamic-pituitary-gonadal feedback loops and hormone regulation.

• Receptor pharmacology: Examining GnRH receptor binding, antagonism kinetics, and downstream signaling pathways.

• Signal transduction research: Studying intracellular cascades activated by GnRH receptor blockade, including cAMP, MAPK, and calcium-mediated pathways.

• Combination experiments: Assessing synergistic or modulatory effects with other endocrine modulators or experimental therapeutics.

• Animal models: Investigating hormone-dependent physiological processes, reproductive biology, and experimental endocrinology.

Degarelix Acetate is supplied as a sterile, research-grade peptide, typically in lyophilized form, with ≥99% purity. It is suitable for in vitro assays, receptor binding studies, and preclinical experimental models. Each batch is verified by HPLC, mass spectrometry, and peptide sequencing to ensure reproducibility, high purity, and bioactivity.

Product Specifications

Mechanism of Action

Degarelix Acetate functions as a selective GnRH receptor antagonist. Its mechanism of action is primarily mediated by competitive binding to GnRH receptors in the anterior pituitary, preventing receptor activation and subsequent downstream hormonal signaling.

GnRH Receptor Blockade

Degarelix binds with high affinity to GnRH receptors, inhibiting receptor-mediated stimulation of LH and FSH secretion. This blockade allows researchers to examine hormonal suppression mechanisms without the confounding initial stimulation (“flare”) observed with GnRH agonists.

Endocrine Feedback Modulation

By preventing GnRH receptor activation, Degarelix indirectly reduces downstream testosterone production in experimental models. This property facilitates studies on pituitary-gonadal axis regulation, hormonal feedback loops, and receptor-mediated endocrine control.

Signal Transduction Modulation

Degarelix antagonism affects intracellular signaling pathways associated with GnRH receptor activation, including calcium mobilization, MAPK, and cAMP-dependent cascades. Laboratory research uses Degarelix to dissect these pathways and their contributions to cellular and systemic endocrine responses.

Research Applications

• Dose-response studies in cell culture and preclinical models

• Hormone suppression assays for reproductive biology research

• Combination experiments with other endocrine modulators

• Investigations of peptide stability, receptor occupancy, and pharmacokinetics

Degarelix’s high receptor specificity and peptide stability make it a reliable reagent for in vitro, ex vivo, and in vivo endocrine research.

Side Effects

In laboratory studies, Degarelix Acetate exhibits minimal cytotoxicity at experimental concentrations. Observed effects may include transient alterations in hormone-sensitive cell proliferation, dependent on dose and experimental conditions. Degarelix is not intended for human or veterinary use outside of laboratory research.

Keywords

Degarelix Acetate, GnRH receptor antagonist, endocrine research, testosterone modulation, pituitary-gonadal axis studies, peptide research chemical, preclinical pharmacology, laboratory research peptide, high-purity peptide, hormone regulation research, factory peptide supplier, peptide wholesale China, cosmetic raw material manufacturer, low-price peptide supplier, China peptide manufacturer, OEM & bulk peptide production

Shipping Guarantee

All shipments of Degarelix Acetate are handled using validated cold-chain logistics to maintain peptide integrity. Each package is sealed in moisture-proof containers with secondary protective wrapping and continuous temperature monitoring. Products are shipped via express international couriers with full tracking and insurance coverage, ensuring safe delivery without degradation.

Trade Assurance

We guarantee the authenticity and high purity (≥99%) of Degarelix Acetate. Each batch undergoes stringent quality control, including HPLC, mass spectrometry, and peptide sequencing to verify molecular identity and purity. Certificates of Analysis (CoA) are provided for each batch. Our trade assurance policy ensures replacement or refund for any deviation from listed specifications.

Payment Support

We provide secure and flexible payment options for global research transactions, including PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). All transactions are encrypted and verified, ensuring confidentiality and fund security.

Disclaimer

All Degarelix Acetate products are intended for laboratory research use only. They are not drugs, medical devices, or diagnostics, and should not be administered to humans or animals. Researchers must adhere to institutional biosafety and chemical safety guidelines. Information provided is for scientific reference only and does not imply therapeutic efficacy, safety, or regulatory approval.